These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12442879)

  • 1. The use of antihistamines in safety-critical jobs: a meeting report.
    Mohler SR; Nicholson A; Harvey P; Miura Y; Meeves SG
    Curr Med Res Opin; 2002; 18(6):332-7. PubMed ID: 12442879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
    Spangler DL; Brunton S
    South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies into the possible central effects of the H-1 receptor antagonist, fexofenadine.
    Stone BM; Turner C; Mills SL; Nicholson AN
    Int Arch Allergy Immunol; 1999; 118(2-4):338. PubMed ID: 10224436
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of second generation antihistamines.
    Philpot EE
    Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation, cognition, and antihistamines.
    Qidwai JC; Watson GS; Weiler JM
    Curr Allergy Asthma Rep; 2002 May; 2(3):216-22. PubMed ID: 11918863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-sedating antihistamines and cardiac arrhythmia.
    Rankin AC
    Lancet; 1997 Oct; 350(9085):1115-6. PubMed ID: 9343494
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety profile of fexofenadine HCl: a unique therapeutic option in H1-receptor antagonist treatment.
    Meeves SG; Appajosyula S
    J Allergy Clin Immunol; 2003 Oct; 112(4 Suppl):S69-77. PubMed ID: 14530791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
    López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
    Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brompheniramine, terfenadine, and placebo in allergic rhinitis.
    Klein GL; Littlejohn T; Lockhart EA; Furey SA
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):365-70. PubMed ID: 8933774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator.
    Weiler JM; Bloomfield JR; Woodworth GG; Grant AR; Layton TA; Brown TL; McKenzie DR; Baker TW; Watson GS
    Ann Intern Med; 2000 Mar; 132(5):354-63. PubMed ID: 10691585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
    Van Cauwenberge P; Juniper EF
    Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic safety of fexofenadine HCl.
    Mason J; Reynolds R; Rao N
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():163-70; discussion 171-3. PubMed ID: 10444232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
    Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
    J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fexofenadine hydrochloride--a new anti-histaminic drug.
    Amichai B; Grunwald MH; Brenner L
    Isr Med Assoc J; 2001 Mar; 3(3):207-9. PubMed ID: 11303380
    [No Abstract]   [Full Text] [Related]  

  • 19. Decongestant effects of antihistamines: a class effect?
    Lipworth BJ; Lee DK; Jackson CM
    J Allergy Clin Immunol; 2003 Mar; 111(3):653; author reply 653-4. PubMed ID: 12642858
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.